FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2272185728> ?p ?o ?g. }

• W2272185728 endingPage "633" @default.
• W2272185728 startingPage "627" @default.
• W2272185728 abstract "Anthracyclines are commonly used chemotherapeutic agents with proven efficacy in such malignancies as breast cancer, Hodgkin and non-Hodgkin lymphomas. These agents are associated with irreversible accumulative dose-related cardiomyopathy. Many agents have been examined to reduce cardiotoxicity risk.We performed a systematic review and meta-analysis to determine the efficacy of β-blockers and angiotensin antagonists to prevent early-onset anthracyclines-induced left ventricular dysfunction and cardiac events.Relevant articles were searched in PubMed, EMBASE and Cochrane database of systematic reviews up to July 2015. Eligible studies were limited to randomised controlled trials comparing the efficacy of cardioprotective agents (β-blocker and angiotensin antagonist) with control (either no treatment or placebo) in adult patients (age >18 years) treated with anthracyclines-based regimens.Pooled analysis showed an association of β-blockers and/or angiotensin antagonists treatment with higher post-chemotherapy left ventricular ejection fraction (LVEF) of 64.03% compared with 57.48% for control treatment. The mean difference estimate (95% CI) was 6.06% (0.54 to 11.58), p=0.03, with significant heterogeneity, I(2) (95% CI)=96% (82.7 to 109.3). Though the point estimate for the relative rate of cardiac events was lower in the experimental arm, the difference was not statistically significant. In an exploratory subgroup analysis, the benefit of experimental agents on LVEF preservation was prominent in patients treated with higher accumulative dose of anthracyclines, but not in the lower dose group.β-Blockers and angiotensin antagonists treatments were associated with better LVEF preservation, and the benefit was prominent in patients treated with higher anthracyclines accumulative dose. Unexplained heterogeneity remains, indicating the need for more controlled studies. This analysis provides some support for the routine use of β-blockers or angiotensin antagonists in patients undergoing anthracyclines treatment, especially when higher accumulative dose is expected." @default.
• W2272185728 created "2016-06-24" @default.
• W2272185728 creator A5011096418 @default.
• W2272185728 creator A5031658471 @default.
• W2272185728 creator A5037828741 @default.
• W2272185728 date "2015-09-23" @default.
• W2272185728 modified "2023-10-18" @default.
• W2272185728 title "Cardioprotective role of β-blockers and angiotensin antagonists in early-onset anthracyclines-induced cardiotoxicity in adult patients: a systematic review and meta-analysis" @default.
• W2272185728 cites W1492360552 @default.
• W2272185728 cites W1961248591 @default.
• W2272185728 cites W1983953026 @default.
• W2272185728 cites W1985536050 @default.
• W2272185728 cites W1998141986 @default.
• W2272185728 cites W2003943979 @default.
• W2272185728 cites W2014166418 @default.
• W2272185728 cites W2036349237 @default.
• W2272185728 cites W2045806344 @default.
• W2272185728 cites W2051550496 @default.
• W2272185728 cites W2055210354 @default.
• W2272185728 cites W2065902339 @default.
• W2272185728 cites W2069030452 @default.
• W2272185728 cites W2073912429 @default.
• W2272185728 cites W2094415834 @default.
• W2272185728 cites W2095689312 @default.
• W2272185728 cites W2096949123 @default.
• W2272185728 cites W2098886952 @default.
• W2272185728 cites W2099190645 @default.
• W2272185728 cites W2104151418 @default.
• W2272185728 cites W2106926141 @default.
• W2272185728 cites W2108969834 @default.
• W2272185728 cites W2109775164 @default.
• W2272185728 cites W2112196039 @default.
• W2272185728 cites W2112351355 @default.
• W2272185728 cites W2125435699 @default.
• W2272185728 cites W2133475821 @default.
• W2272185728 cites W2137409323 @default.
• W2272185728 cites W2139731996 @default.
• W2272185728 cites W2140182328 @default.
• W2272185728 cites W2142877037 @default.
• W2272185728 cites W2145860233 @default.
• W2272185728 cites W2156698079 @default.
• W2272185728 cites W2165287255 @default.
• W2272185728 cites W2468996569 @default.
• W2272185728 cites W2758325167 @default.
• W2272185728 cites W4255787167 @default.
• W2272185728 doi "https://doi.org/10.1136/postgradmedj-2015-133535" @default.
• W2272185728 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26399268" @default.
• W2272185728 hasPublicationYear "2015" @default.
• W2272185728 type Work @default.
• W2272185728 sameAs 2272185728 @default.
• W2272185728 citedByCount "42" @default.
• W2272185728 countsByYear W22721857282015 @default.
• W2272185728 countsByYear W22721857282016 @default.
• W2272185728 countsByYear W22721857282017 @default.
• W2272185728 countsByYear W22721857282018 @default.
• W2272185728 countsByYear W22721857282019 @default.
• W2272185728 countsByYear W22721857282020 @default.
• W2272185728 countsByYear W22721857282021 @default.
• W2272185728 countsByYear W22721857282022 @default.
• W2272185728 countsByYear W22721857282023 @default.
• W2272185728 crossrefType "journal-article" @default.
• W2272185728 hasAuthorship W2272185728A5011096418 @default.
• W2272185728 hasAuthorship W2272185728A5031658471 @default.
• W2272185728 hasAuthorship W2272185728A5037828741 @default.
• W2272185728 hasBestOaLocation W22721857281 @default.
• W2272185728 hasConcept C126322002 @default.
• W2272185728 hasConcept C142724271 @default.
• W2272185728 hasConcept C143998085 @default.
• W2272185728 hasConcept C164705383 @default.
• W2272185728 hasConcept C187960798 @default.
• W2272185728 hasConcept C204787440 @default.
• W2272185728 hasConcept C27081682 @default.
• W2272185728 hasConcept C2776694085 @default.
• W2272185728 hasConcept C2778198053 @default.
• W2272185728 hasConcept C2778233292 @default.
• W2272185728 hasConcept C2778797674 @default.
• W2272185728 hasConcept C71924100 @default.
• W2272185728 hasConcept C78085059 @default.
• W2272185728 hasConcept C95190672 @default.
• W2272185728 hasConcept C98274493 @default.
• W2272185728 hasConceptScore W2272185728C126322002 @default.
• W2272185728 hasConceptScore W2272185728C142724271 @default.
• W2272185728 hasConceptScore W2272185728C143998085 @default.
• W2272185728 hasConceptScore W2272185728C164705383 @default.
• W2272185728 hasConceptScore W2272185728C187960798 @default.
• W2272185728 hasConceptScore W2272185728C204787440 @default.
• W2272185728 hasConceptScore W2272185728C27081682 @default.
• W2272185728 hasConceptScore W2272185728C2776694085 @default.
• W2272185728 hasConceptScore W2272185728C2778198053 @default.
• W2272185728 hasConceptScore W2272185728C2778233292 @default.
• W2272185728 hasConceptScore W2272185728C2778797674 @default.
• W2272185728 hasConceptScore W2272185728C71924100 @default.
• W2272185728 hasConceptScore W2272185728C78085059 @default.
• W2272185728 hasConceptScore W2272185728C95190672 @default.
• W2272185728 hasConceptScore W2272185728C98274493 @default.
• W2272185728 hasIssue "1081" @default.
• W2272185728 hasLocation W22721857281 @default.
• W2272185728 hasLocation W22721857282 @default.

• next